New Community for SAS Drug Development Users

It has been a while since I got to announce a new community for SAS users.  Our latest community contains great information targeted at users of SAS Drug Development.  This community deviates from our usual offering.  The SAS Drug Development Forum is not available for guest (anonymous) users to read.  You must have a SAS Web Profile and you must log in to read the contents of this community.

You will want to log in and have a look around.  The SAS Drug Development team has populated the space with some great content.  They are just waiting for you to join the discussion.  The following text is an excerpt from the welcome message:

We encourage you  to participate in all of these activities by initiating and responding to discussions and posting articles that you believe are relevant to your peers. 

Be an active member of this community.  To get started:

  1. Log in to communities.sas.com and visit SAS Drug Development Forum.
  2. Look for the Actions box on the right and select Start a discussion or Write an article.  Use the editor to create and submit your text.
  3. If you don't want to create new text, comment on one of the discussions or articles that have been added.
  4. Don't miss any of this content. Select Follow from the top of the page or Track in Communications from the Actions box.  Then watch your Communications page or your inbox for content updates.  Read more about the Communications Stream.

 

 

 

tags: community updates

3 Comments

  1. Quentin McMullen
    Posted July 4, 2012 at 10:09 pm | Permalink

    I'm curious as to why the decision was made not to allow anonymous browsing? (not that it's a bad decision, just curious as to why it makes sense for only that one community).

    • Posted July 9, 2012 at 8:49 am | Permalink

      In the beginning (which was >8 years ago), we wanted to encourage as many people as possible to get value from the discussion forum content. That meant allowing external search engines to index the content and anonymous browsing. When we had sensitive topics, we restricted those topics to just people who were specifically added to the forum. Those topics weren't very successful. Out of site; out of mind.

      When the SAS Drug Development team approached us about creating a community for SDD users, we decided to restrict browsing and search indexing because this is a regulated industry and felt that users would be more comfortable with some restrictions in place.

      We'd love to hear what you all think.

  2. Satya Mohanty
    Posted January 29, 2013 at 10:33 am | Permalink

    We have several Clinical SAS contract positions with Novartis at Florham, Park, NJ.Please email me your resumes. (satya.mohanty@tech-observer.com)

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <p> <pre lang="" line="" escaped=""> <q cite=""> <strike> <strong>